Please Wait.....
Report
North America Cold Sore Treatment (for HSV 1 Virus) Market
Market Report I 2023-02-01 I 144 Pages I Data Bridge Market Research
The North America cold sore treatment (for HSV 1 virus) market is projected to register a substantial CAGR of 5.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
North America Cold Sore Treatment (for HSV 1 Virus) Market, By Product Type (Medications, Ointments, Creams, Medicated Lip Balms, Cold Sore Patches, and Non-Medicated Products), Route of Administration (Oral, Topical, and Others), Type (Prescription Drugs and Over The Counter (OTC) Drugs), Gender (Male and Female), Drug Type (Branded and Generics), End User (Hospitals, Specialty Clinics, Homecare Setting, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 203
Some of the major factors contributing to the growth of the North America cold sore treatment (for HSV 1 virus) market are:
- High prevalence of cold sore infections
- Rising company activities in developing products
Market Players
Some of the major market players operating in the North America cold sore treatment (for HSV 1 virus) market are listed below:
- Amparo medical Technologies
- Apotex Inc.
- Bausch Health Companies Inc.
- Blistex Inc.
- Carma Labs Inc.
- Church & Dwight Co., Inc.
- GSK plc.
- Haleon Group of Companies
- Hikma Pharmaceuticals PLC
- HRA Pharma
- Novartis AG
- Quantum Health
- Teva Pharmaceuticals USA, Inc.
- URGO
- Viatris Inc.
- Zydus Pharmaceuticals, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 19
2.1 MARKETS COVERED 19
2.2 GEOGRAPHICAL SCOPE 20
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 CURRENCY AND PRICING 20
2.5 DBMR TRIPOD DATA VALIDATION MODEL 21
2.6 MULTIVARIATE MODELLING 24
2.7 PRODUCT TYPE LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 MARKET END USER COVERAGE GRID 28
2.11 SECONDARY SOURCES 29
2.12 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 33
4.1 PESTEL ANALYSIS 34
4.2 PORTER'S FIVE FPRCES 35
5 INDUSTRY INSIGHTS 36
6 REGULATORY FRAMEWORK 38
6.1 REGULATIONS IN THE U.S. 38
6.2 REGULATIONS IN CANADA 39
6.3 REGULATIONS IN MEXICO 39
7 MARKET OVERVIEW 41
7.1 DRIVERS 43
7.1.1 GROWING PREVALENCE OF COLD SORE INFECTION 43
7.1.2 PROLIFERATION IN MODES OF TRANSMISSION OF HERPES SIMPLEX VIRUS 43
7.1.3 AVAILABILITY OF GENERIC DRUGS 44
7.1.4 RISING DISPOSABLE INCOME AND INCREASING HEALTHCARE INFRASTRUCTURE 44
7.2 RESTRAINTS 45
7.2.1 THE DEARTH OF AWARENESS ABOUT THE ONSET AND SYMPTOMS OF COLD SORE AND ITS TREATMENT 45
7.2.2 PATENT TERMINATION OF MARKETED DRUGS 45
7.3 OPPORTUNITIES 46
7.3.1 INCREASING USE OF COLD SORE PATCHES 46
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 47
3.3 INCREASING RESEARCH AND DEVELOPMENT FOR COLD SORE PATCHES 47
3.4 RISE IN THE DEMAND FOR ANTI-VIRAL DRUGS FOR COLD SORE TREATMENT 48
7.4 CHALLENGES 49
7.4.1 SIDE EFFECTS ASSOCIATED WITH MEDICATIONS USED FOR TREATING COLD SORES 49
7.4.2 RISE IN THE ADOPTION OF ALTERNATIVE HOME REMEDIES FOR COLD SORE TREATMENT 49
8 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY DRUG TYPE 51
8.1 OVERVIEW 52
8.2 MEDICATIONS 55
8.2.1 ANTIVIRAL AGENTS 55
8.2.1.1 ACYCLOVIR 56
8.2.1.2 FAMCICLOVIR 56
8.2.1.3 VALACYCLOVIR 56
8.2.1.4 OTHERS 56
8.2.2 ANALGESICS AGENTS 56
8.2.3 OTHERS 56
8.3 OINTMENTS 56
8.3.1 GENERICS 57
8.3.2 BRANDED 57
8.3.2.1 ABREVA 58
8.3.2.2 BLISTEX 58
8.3.2.3 OTHERS 58
8.4 CREAMS 58
8.5 MEDICATED LIP BALMS 58
8.6 COLD SORE PATCHES 59
8.6.1 SEMI OCCLUSIVE HYDROCOLLOID PATCH 59
8.6.2 FILM-FORMING PATCH 59
8.7 NON-MEDICATED PRODUCTS 60
9 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY ROUTE OF ADMINISTRATION 61
9.1 OVERVIEW 62
9.2 ORAL 65
9.2.1 TABLET 65
9.2.2 CAPSULE 65
9.2.3 OTHERS 65
9.3 TOPICAL 65
9.3.1 OINTMENTS 66
9.3.2 CREAMS 66
9.3.3 LIP BALM 66
9.4 OTHERS 66
10 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY TYPE 68
10.1 OVERVIEW 69
10.2 OVER THE COUNTER (OTC) DRUGS 72
10.3 PRESCRIPTION DRUGS 72
11 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY GENDER 73
11.1 OVERVIEW 74
11.2 FEMALE 77
11.3 MALE 77
12 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY DRUG TYPE 78
12.1 OVERVIEW 79
12.2 GENERICS 82
12.3 BRANDED 82
13 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY END-USER 83
13.1 OVERVIEW 84
13.2 HOMECARE SETTING 87
13.3 HOSPITALS 87
13.4 SPECIALTY CLINICS 87
13.5 OTHERS 88
14 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY DISTRIBUTION CHANNEL 89
14.1 OVERVIEW 90
14.2 RETAIL PHARMACY 93
14.3 HOSPITAL PHARMACY 93
14.4 ONLINE PHARMACY 94
15 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET BY COUNTRY 95
15.1 NORTH AMERICA 95
15.1.1 U.S. 101
15.1.2 CANADA 105
15.1.3 MEXICO 109
16 NORTH AMERICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET: COMPANY LANDSCAPE 113
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 113
17 SWOT ANALYSIS 114
18 COMPANY PROFILES 115
18.1 GSK PLC. 115
18.1.1 COMPANY SNAPSHOT 115
18.1.2 REVENUE ANALYSIS 115
18.1.3 PRODUCT PORTFOLIO 116
18.1.4 RECENT DEVELOPMENT 116
18.2 HALEON GROUP OF COMPANIES 117
18.2.1 COMPANY SNAPSHOT 117
18.2.2 REVENUE ANALYSIS 117
18.2.3 PRODUCT PORTFOLIO 118
18.2.4 RECENT DEVELOPMENT 118
18.3 VIATRIS INC. 119
18.3.1 COMPANY SNAPSHOT 119
18.3.2 REVENUE ANALYSIS 119
18.3.3 PRODUCT PORTFOLIO 120
18.3.4 RECENT DEVELOPMENTS 120
18.4 QUANTUM HEALTH 121
18.4.1 COMPANY SNAPSHOT 121
18.4.2 PRODUCT PORTFOLIO 121
18.4.3 RECENT DEVELOPMENTS 121
18.5 TEVA PHARMACEUTICALS USA, INC. (SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.) 122
18.5.1 COMPANY SNAPSHOT 122
18.5.2 REVENUE ANALYSIS 122
18.5.3 PRODUCT PORTFOLIO 123
18.5.4 RECENT DEVELOPMENT 123
18.6 AMPARO MEDICAL TECHNOLOGIES 124
18.6.1 COMPANY SNAPSHOT 124
18.6.2 PRODUCT PORTFOLIO 124
18.6.3 RECENT DEVELOPMENT 124
18.7 APOTEX INC. 125
18.7.1 COMPANY SNAPSHOT 125
18.7.2 PRODUCT PORTFOLIO 125
18.7.3 RECENT DEVELOPMENTS 125
18.8 BAUSCH HEALTH COMPANIES INC. 126
18.8.1 COMPANY SNAPSHOT 126
18.8.2 REVENUE ANALYSIS 126
18.8.3 PRODUCT PORTFOLIO 127
18.8.4 RECENT DEVELOPMENT 127
18.9 BLISTEX INC. 128
18.9.1 COMPANY SNAPSHOT 128
18.9.2 PRODUCT PORTFOLIO 128
18.9.3 RECENT DEVELOPMENT 128
18.10 CARMA LABS INC. 129
18.10.1 COMPANY SNAPSHOT 129
18.10.2 PRODUCT PORTFOLIO 129
18.10.3 RECENT DEVELOPMENT 129
18.11 CHURCH & DWIGHT CO., INC. 130
18.11.1 COMPANY SNAPSHOT 130
18.11.2 REVENUE ANALYSIS 130
18.11.3 PRODUCT PORTFOLIO 131
18.11.4 RECENT DEVELOPMENT 131
18.12 HIKMA PHARMACEUTICALS PLC 132
18.12.1 COMPANY SNAPSHOT 132
18.12.2 REVENUE ANALYSIS 132
18.12.3 PRODUCT PORTFOLIO 133
18.12.4 RECENT DEVELOPMENTS 133
18.13 HRA PHARMA 134
18.13.1 COMPANY SNAPSHOT 134
18.13.2 PRODUCT PORTFOLIO 134
18.13.3 RECENT DEVELOPMENTS 134
18.14 NOVARTIS AG 135
18.14.1 COMPANY SNAPSHOT 135
18.14.2 REVENUE ANALYSIS 135
18.14.3 PRODUCT PORTFOLIO 136
18.14.4 RECENT DEVELOPMENTS 136
18.15 URGO 137
18.15.1 COMPANY SNAPSHOT 137
18.15.2 PRODUCT PORTFOLIO 137
18.15.3 RECENT DEVELOPMENTS 137
18.16 ZYDUS PHARMACEUTICALS, INC. (SUBSIDIARY OF ZYDUS GROUP) 138
18.16.1 COMPANY SNAPSHOT 138
18.16.2 REVENUE ANALYSIS 138
18.16.3 PRODUCT PORTFOLIO 139
18.16.4 RECENT DEVELOPMENT 139
19 QUESTIONNAIRE 140
20 RELATED REPORTS 144
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security